Medicare CAR-T Coverage Decision Appears Hung Up In Political Review, Former CMS Official Says

Proliferation of expensive accelerated approval products requires "a revision to the existing evidence and policy approach for payers," Sean Tunis tells the DIA annual meeting.

The delay in issuing a final coverage decision for CAR-T therapies in the US Medicare program suggests the issue is being debated at a political level, Sean Tunis said on 25 June during the DIA annual meeting in San Diego.

Tunis, who served as chief medical officer of the Center for Medicare and Medicaid Services from 2000 to 2006, noted...

More from Medicare

More from Government Payers